Translational Research Opportunities in HFpEF

---

LIVECMECNE

Friday, April 23, 2021, 12:00 PM - 6:00 PM EST, Online, Philadelphia, PA

This session will be held on Friday, April 23, 2021 from 12:00 pm - 5:30 pm. You must register for this or any of the other UPenn HFpEF Symposium 2021 sessions through the main landing page.

Pre-registered attendees will receive access to a PDF of the slides 24 hours in advance of the conference. Only registrants whose attendance has been verified will have continued access to the slides, as well as the recordings.

Links to the other sessions:

Friday, April 9, 2021: Diagnostic Strategies in the Clinical Management of HFpEF

Friday, April 16, 2021: Therapeutic Strategies in the Clinical Management of HFpEF

1. Review the diagnostic criteria for HFpEF, including when to use advanced imaging or hemodynamic assessment
2. Explain HFpEF mimickers, including amyloidosis, sarcoidosis, and inherited cardiomyopathies
3. Discuss the role of non-cardiac structures (such as the arterial system and other organs) in the pathogenesis and treatment of HFpEF
4. Describe the electrophysiologic manifestations of HFpEF and their treatments
5. Discuss ongoing research efforts in cardiology, including pharmacologic and interventional approaches
6. Review ongoing research efforts beyond cardiology

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

All activities listed on this transcript have been approved for AMA PRA Category 1 Credit™.

AMA PRA Category 1 Credits™ (4.50 hours), Non-Physician Attendance / Participation (4.50 hours), Nursing Contact Hours (4.50 hours)

Friday, April 23, 2021